Anhui Guotai Biotechnology Co., Ltd has once again won scientific research results-cardiovascular and cerebrovascular prevention and treatment will usher in a new era
After rejecting the request of scientific research institutions in Japan, the United States, Germany and South Korea to jointly develop red marrow peptide, Guotai Group announced that it would realize the scientific research achievement of full-effect healing of cardiovascular and cerebrovascular systems---red marrow peptide superactive peptide.
- BEIJING, July 14, 2023 /PRNewswire/ -- Anhui Guotai Biotechnology Co., Ltd has once again won scientific research results-cardiovascular and cerebrovascular prevention and treatment may usher in a new era.
- After scientific and technological research for 13 years, Guotai research team extracted the active polypeptides of plateau organisms from the spinal cord of young yaks in no-human land of Qinghai.
- The human body can also solve multi-system related diseases such as cardiovascular and cerebrovascular diseases, immunity and metabolism through oral administration.
- How to thoroughly improve and solve this problem from the root causes has always been one of the key research topics of the Guotai research team.